ストックスクリーナーアプリを入手
13.81
4.69%
-0.68
アフターアワーズ：
13.55
-0.26
-1.88%
前日終値:
$14.49
開ける：
$14.23
24時間の取引高:
3.94M
Relative Volume:
1.67
時価総額：
$4.34B
収益：
$2.68B
当期純損益:
$-184.45M
株価収益率:
-20.29
EPS:
-0.6805
ネットキャッシュフロー:
$229.23M
1週間 パフォーマンス:
-4.76%
1か月 パフォーマンス:
-0.14%
6か月 パフォーマンス:
+47.54%
1年 パフォーマンス:
+64.80%
1日の値動き範囲:
$13.52
$14.66
1週間の範囲:
$13.52
$14.84
52週間の値動き範囲:
$6.685
$15.42
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
名前
Amneal Pharmaceuticals Inc
セクター
電話
908-947-3120
住所
400 Crossing Boulevard, 3rd Floor, Bridgewater
Compare AMRX vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
13.81 | 4.56B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.75 | 58.54B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
131.10 | 54.78B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
11.07 | 47.92B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.86 | 39.33B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
503.90 | 21.68B | 3.13B | 1.27B | 1.12B | 26.39 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-06 | 開始されました | Goldman | Buy |
| 2025-02-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-09-06 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | アップグレード | Goldman | Sell → Buy |
| 2020-12-14 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-12-14 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-27 | 開始されました | Goldman | Sell |
| 2020-05-12 | アップグレード | Guggenheim | Sell → Neutral |
| 2019-12-12 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-11-07 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-21 | アップグレード | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | 開始されました | SunTrust | Buy |
| 2019-03-08 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | ダウングレード | SunTrust | Buy → Hold |
| 2018-08-13 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | 開始されました | Morgan Stanley | Overweight |
| 2018-06-22 | 開始されました | B. Riley FBR, Inc. | Buy |
すべてを表示
Amneal Pharmaceuticals Inc (AMRX) 最新ニュース
Amneal Pharmaceuticals earnings on deck amid growth transition - Investing.com
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Trading Momentum And Modest Undervaluation Estimate - simplywall.st
Earnings Outlook For Amneal Pharmaceuticals - Benzinga
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow - Finviz
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now? - Yahoo Finance
Jobs Data: Is Amneal Pharmaceuticals Inc in a long term uptrend2025 Dividend Review & AI Driven Stock Price Forecasts - baoquankhu1.vn
Gains Recap: Will Global Ship Lease Inc stock hit new highs in YEARJuly 2025 Movers & Fast Gain Stock Trading Tips - baoquankhu1.vn
Is Amneal Pharmaceuticals Inc in a long term uptrendQuarterly Profit Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn
Is Amneal Pharmaceuticals Inc. stock undervalued right nowM&A Rumor & Weekly High Momentum Picks - mfd.ru
Will Amneal Pharmaceuticals Inc. stock benefit from green energy trendsJuly 2025 Snapshot & Weekly Top Gainers Trade List - mfd.ru
What are the future prospects of Amneal Pharmaceuticals Inc.Gap Up & Weekly Top Performers Watchlists - mfd.ru
Aug PreEarnings: How sensitive is Amneal Pharmaceuticals Inc to inflationJuly 2025 Trends & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Collegium Pharmaceutical to Report Q4 Earnings: What's in the Cards? - Finviz
Amneal Pharmaceuticals stock hits 52-week high at 15.08 USD By Investing.com - Investing.com Canada
Amneal Pharmaceuticals, Inc. (AMRX) Added to S&P SmallCap 600 Index, Boosting Investor Visibility - Finviz
Amneal Pharmaceuticals (NASDAQ:AMRX) Sets New 52-Week HighShould You Buy? - MarketBeat
Amneal Pharmaceuticals stock hits 52-week high at 15.08 USD - Investing.com Nigeria
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds - Insider Monkey
Is Amneal Pharmaceuticals Inc. a potential multi bagger2025 Winners & Losers & AI Powered Trade Plan Recommendations - mfd.ru
Travel Stocks: Is Amneal Pharmaceuticals Inc a strong candidate for buy and holdLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Is Amneal Pharmaceuticals Inc. forming a double bottomJuly 2025 Snapshot & Capital Efficient Trade Techniques - mfd.ru
Resistance Check: How does Amneal Pharmaceuticals Inc perform in inflationary periodsPortfolio Value Summary & Smart Money Movement Tracker - baoquankhu1.vn
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market - Benzinga
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 87.3% in January - MarketBeat
What makes Amneal Pharmaceuticals Inc. stock attractive todayOptions Play & AI Forecasted Stock Moves - mfd.ru
What Amneal Pharmaceuticals (AMRX)'s Addition to the S&P 1000 Index Means For Shareholders - Yahoo Finance
Options Flow: Can Amneal Pharmaceuticals Inc continue delivering strong returns2025 Technical Patterns & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Is Amneal Pharmaceuticals Inc. in a long term uptrend2025 Momentum Check & Long-Term Growth Portfolio Plans - mfd.ru
Doseology Sciences Launches New Energy Product Line - Intellectia AI
What Amneal Pharmaceuticals (AMRX)'s Index Additions and Opioid Settlement Mean For Shareholders - simplywall.st
Earnings Report: Will Amneal Pharmaceuticals Inc benefit from current market trendsWeekly Risk Report & Verified Momentum Watchlists - baoquankhu1.vn
What are the future prospects of Amneal Pharmaceuticals IncJuly 2025 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn
Amneal Receives FDA Approval for Sodium Oxybate Oral Solution - Sleep Review
Breakouts Watch: What’s the outlook for SPAR Group Inc.’s sectorTrade Analysis Summary & High Win Rate Trade Alerts - baoquankhu1.vn
Is Amneal Pharmaceuticals (AMRX) a great value stock right now? - MSN
Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now? - Yahoo Finance
Guidance Update: Is Amneal Pharmaceuticals Inc a strong candidate for buy and holdTrade Analysis Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Amneal Pharmaceuticals Refinances Term Loans, Lowers Interest Costs - TipRanks
Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit AgreementSEC Filing - TradingView
Amneal Pharmaceuticals Signs Term Loan Credit Agreement Amendment With JPMorgan Chase - TradingView
How Investors Are Reacting To Amneal Pharmaceuticals (AMRX) Index Additions And Opioid Settlement Resolution - Sahm
Will Amneal (AMRX) beat estimates again in its next earnings report? - MSN
Amneal initiates nationwide settlement for opioid-related claims - MSN
Aug Sentiment: Is Amneal Pharmaceuticals Inc stock a hidden gem2025 Pullback Review & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Risk Check: Does Ormat Technologies Inc stock benefit from AI growth2025 Market Outlook & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
AustralianSuper Pty Ltd Makes New Investment in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi‑Year Share Price Run? - Yahoo Finance
Opioid Settlement And Index Inclusion Reframe Amneal Pharmaceuticals Risk And Reach - Yahoo Finance
Published on: 2026-01-30 06:37:48 - baoquankhu1.vn
Amneal initiates nationwide opioid settlement (AMRX:NASDAQ) - Seeking Alpha
Amneal Pharmaceuticals Inc (AMRX) 財務データ
収益
当期純利益
現金流量
EPS
1.37%
0.80%
大文字化:
|
ボリューム (24 時間):